Veterinary Medicines

CANIGEN DHPPI LYOPHILISATE AND SOLVENT FOR SUSPENSION FOR INJECTION FOR DOGS

Authorised
  • Canine parvovirus, strain Cornell 780916, Live
  • Canine distemper virus, strain Lederle, Live
  • Canine adenovirus 2, strain Manhattan, Live
  • Water for injection
  • Canine parainfluenza virus, strain Manhattan, Live
Download as PDF

Product identification

Medicine name:
CANIGEN DHPPI LYOPHILISATE AND SOLVENT FOR SUSPENSION FOR INJECTION FOR DOGS
Canigen DHPPi liofilizāts un šķīdinātājs suspensijas injekcijām pagatavošanai suņiem
Active substance:
  • Canine parvovirus, strain Cornell 780916, Live
  • Canine distemper virus, strain Lederle, Live
  • Canine adenovirus 2, strain Manhattan, Live
  • Water for injection
  • Canine parainfluenza virus, strain Manhattan, Live
Target species:
  • Dog
Route of administration:
  • Subcutaneous use

Product details

Active substance and strength:
  • Canine parvovirus, strain Cornell 780916, Live
    100000.00
    tissue culture infective dose 50
    /
    1.00
    unit(s)
  • Canine distemper virus, strain Lederle, Live
    1000.00
    tissue culture infective dose 50
    /
    1.00
    unit(s)
  • Canine adenovirus 2, strain Manhattan, Live
    10000.00
    tissue culture infective dose 50
    /
    1.00
    unit(s)
  • Water for injection
    1.00
    millilitre(s)
    /
    1.00
    unit(s)
  • Canine parainfluenza virus, strain Manhattan, Live
    100000.00
    tissue culture infective dose 50
    /
    1.00
    unit(s)
Pharmaceutical form:
  • Lyophilisate and solvent for suspension for injection
Withdrawal period by route of administration:
  • Subcutaneous use
    • Dog
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QI07AD04
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Latvia
Package description:
  • Cardboard box of 5 vials lyophilisate and 5 vials solvent
  • Cardboard boxof 10 vials lyophilisate and 10 vials solvent
  • Cardboard box of 25 vials lyophilisate and 25 vials solvent
  • Cardboard box of 50 vials lyophilisate and 50 vials solvent
  • Cardboard box of 100 vials lyophilisate and 100 vials solvent
  • Plastic box of 1 vial lyophilisate and 1 vial solvent
  • Plastic box of 5 vials lyophilisate and 5 vials solvent
  • Plastic box of 10 vials lyophilisate and 10 vials solvent
  • Plastic box of 25 vials lyophilisate and 25 vials solvent
  • Plastic box of 50 vials lyophilisate and 50 vials solvent
  • Plastic box of 100 vials lyophilisate and 100 vials solvent
  • Cardboard box of 1 vial lyophilisate and 1 vial solvent

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Full application - Known active substance (Article 12(3) of Directive No 2001/82/EC)
Marketing authorisation holder:
  • Virbac
Marketing authorisation date:
Manufacturing sites for batch release:
  • Virbac
Responsible authority:
  • Food And Veterinary Service
Authorisation number:
  • V/DCP/16/0014
Date of authorisation status change:
Reference member state:
  • France
Procedure number:
  • FR/V/0297/001
Concerned member states:
  • Austria
  • Belgium
  • Bulgaria
  • Croatia
  • Cyprus
  • Czechia
  • Denmark
  • Estonia
  • Finland
  • Germany
  • Greece
  • Hungary
  • Ireland
  • Italy
  • Latvia
  • Lithuania
  • Luxembourg
  • Malta
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Romania
  • Slovakia
  • Slovenia
  • Spain
  • Sweden
  • United Kingdom (Northern Ireland)

Documents

Labelling

This document does not exist in this language (English). You can find it in another language below.
Latvian (PDF)
Published on: 1/03/2024
Download

Package Leaflet

This document does not exist in this language (English). You can find it in another language below.
Latvian (PDF)
Published on: 1/03/2024
Download

Summary of Product Characteristics

This document does not exist in this language (English). You can find it in another language below.
Latvian (PDF)
Published on: 1/03/2024
Download
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."